11. Psoralen derivatives as inhibitors of mycobacterium tuberculosis proteasomeKaja Rožman, Evan M. Alexander, Eva Ogorevc, Krištof Bozovičar, Izidor Sosič, Courtney C. Aldrich, Stanislav Gobec, 2020, original scientific article Keywords: protein degradation, proteasome, Mycobacterium tuberculosis, psoralens, nonpeptidic proteasome inhibitors Full text (file, 6,28 MB) This document has more files! More... |
12. Novel selective IDO1 inhibitors with isoxazolo[5,4-d]pyrimidin-4(5H)-one scaffoldAna Dolšak, Tomaž Bratkovič, Larisa Mlinarič, Eva Ogorevc, Urban Švajger, Stanislav Gobec, Matej Sova, 2021, original scientific article Keywords: indoleamine 2, 3-dioxygenase 1, selective inhibitors, isoxazolo[5, 4-d]pyrimidin-4(5H)-one, immunomodulation, cancer Full text (file, 19,67 MB) This document has more files! More... |
13. Prioritisation of compounds for 3CL$^{pro}$ inhibitor development on SARS-CoV-2 variantsMarko Jukič, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik, Urban Bren, 2021, original scientific article Keywords: COVID-19, SARS-CoV-2, free-energy calculations, in silico drug design, virtual screening, inhibitors, 3C-like protease, M$^{pro}$, 3CL$^{pro}$, high-throughput, chemical library design, machine learning, compound prioritisation Full text (file, 6,56 MB) This document has more files! More... |
14. 4-phenethyl-1-propargylpiperidine-derived dual inhibitors of butyrylcholinesterase and monoamine oxidase BTjaša Mazej, Damijan Knez, Anže Meden, Stanislav Gobec, Matej Sova, 2021, original scientific article Keywords: Alzheimer's disease, butyrylcholinesterase, monoamine oxidase B, inhibitors, multi-target-directed ligands, multifunctional ligands Full text (file, 3,88 MB) This document has more files! More... |
15. A fine-tuned lipophilicity/hydrophilicity ratio governs antibacterial potency and selectivity of bifurcated halogen bond-forming NBTIsAnja Kolarič, Maja Kokot, Martina Hrast, Matjaž Weiss, Irena Zdovc, Jurij Trontelj, Simon Žakelj, Marko Anderluh, Nikola Minovski, 2021, original scientific article Keywords: antibacterials, drug discovery, DNA gyrase inhibitors, topoisomerase IV inhibitors, intercalators, novel bacterial topoisomerase inhibitors, topoisomerase II inhibitors, intercalating agents Full text (file, 6,80 MB) This document has more files! More... |
16. Molecular dynamics-derived pharmacophore model explaining the nonselective aspect of K$_V$10.1 pore blockersŽan Toplak, Franci Merzel, Luis A. Pardo, Lucija Peterlin-Mašič, Tihomir Tomašič, 2021, original scientific article Keywords: cancer, Eag1, hERG, K$_V$10.1 inhibitors, molecular dynamics, pharmacophore Full text (file, 10,02 MB) This document has more files! More... |
|
18. Fragment-sized and bidentate (immuno)proteasome inhibitors derived from cysteine and threonine targeting warheadsLevente Kollár, Martina Gobec, Matic Proj, Lara Smrdel, Damijan Knez, Stanislav Gobec, Izidor Sosič, György Keserü M., 2021, original scientific article Keywords: immunoproteasome, benzoxazole-2-carbonitriles, bidentate covalent inhibitors, fragments, non-covalent recognition Full text (file, 1,17 MB) This document has more files! More... |
19. Inhibition of MurA enzyme from Escherichia coli and Staphylococcus aureus by diterpenes from Lepechinia meyenii and their synthetic analogsMacarena Funes Chabán, Martina Hrast, Rok Frlan, Dafni G. Graikioti, Constantinos M. Athanassopoulos, María Cecilia Carpinella, 2021, original scientific article Keywords: dehydroabietane derivatives, diterpenes, MurA inhibitors, MurF inhibitors, Staphylococcus aureus MurA, Escherichia coli MurA Full text (file, 2,12 MB) This document has more files! More... |
20. Upregulation of cathepsin X in glioblastomaBernarda Majc, Anamarija Habič, Metka Novak, Ana Rotter, Andrej Porčnik, Jernej Mlakar, Vera Župunski, Urša Pečar Fonović, Damijan Knez, Nace Zidar, Stanislav Gobec, Janko Kos, Tamara Lah Turnšek, Anja Pišlar, Barbara Breznik, 2022, original scientific article Keywords: glioblastoma, cathepsin X, γ-enolase, tumor microenvironment, glioblastoma stem cells, cathepsin X inhibitors Full text (file, 3,50 MB) This document has more files! More... |